Latest therapeutics News | Page 10

Jessica’s story, ovarian cancer at young age
New centre to develop treatments for aggressive cancers
Opthea announces leadership transition with the appointment of US-based executives
AusBioInvest 2023 connects innovators with investment
Public support needed to advance treatment in deadly brain cancers
AusBioInvest 2023 marks beginning of Australia’s biggest week in biotech
WA’s innovative healthcare to be showcased on open day
FDA grants Certa Therapeutics’ FT011 orphan drug designation for systemic sclerosis
AusBioInvest 2023 programme launched
‘We could see it happening before our eyes’: research shows how cancer cells resist chemotherapy
Enhertu demonstrated clinically meaningful survival across multiple HER2-expressing advanced solid tumours in DESTINY-PanTumor02 Phase II trial
Prescient to announce Phase 1b cancer trial results at world’s largest haematology conference
$15 million for research to better treat prostate and childhood cancer
$15 million for new cancer fighting research centre
Arovella Therapeutics licences monoclonal antibody for cell therapy development
Targeting unsuspected protein reverses lymphedema
Research reveals how disordered proteins contribute to the properties of the rabies virus
Research brings better understanding of how disordered proteins contribute to the properties of the rabies virus
Breakthrough in understanding immune responses in inflammatory bowel and lung disease
Viralgen Vector Core and Elpida Therapeutics partner to manufacture gene therapy medicines for anticipated Spastic Paraplegia 50 (SPG50) and Charcot-Marie-Tooth disease type…
Starpharma announces the presentation of DEP irinotecan combination data
Improve use of medicines and medical tests with $26 million in grants
HealthTech InnovationAus award finalists announced
Research assistant Michael Hutton publishes review on atherosclerosis research
NIH Center grant bolsters male contraceptive research
New target to beat cancer drug resistance
Tiny fish could be key to develop treatment against MND
Australian-developed drug receives US FDA approval
Ultrathin nanotech promises to help tackle antibiotic resistance
Top Perth blood cancer researcher wins prestigious award
Non-animal models could deliver $1.5B growth
‘Introspective’ AI Finds Diversity Improves Performance
Nanoneedle breakthrough gives hope for cheaper cancer treatment
Nominations open for AusBiotech Board 22 August
Pill could provide alternative to weight loss surgery
A prescription product to help people at risk of dying by suicide
Fast Five with Jonathan Lozano-Salgado
Can the body’s signalling protein be harnessed to stop ovarian cancer?
Chimeric reports positive in-vitro data for CHM 0301 next-generation cell platform
Monash University and Moderna form partnership to advance homegrown mRNA medicines
Potential neuropathic pain treatment shows promise in preclinical tests
Australian vaccine breakthrough offers hope against EBV-associated cancers and MS
Universal siRNA Covid treatment shows promise in lab
Landmark public health decisions by WHO on essential medicines for alcohol use disorders
Researchers investigate new therapy to heal osteoporosis fractures
Scientists push boundaries in flu fight
New AusBiotech report shows increasing US investment in Australian biotechs
Allarity Therapeutics and FivepHusion announce collaboration for the development of Deflexifol with DRP Companion Diagnostics